novo nordisk semaglutide pill Wegovy media kit Novo Nordisk's Wegovy® pill, the

Novo has responded with newer treatment options, including the higher Wegovy dose at issue in the lawsuit

No complicated intake processes

The 7-day interval is a target, not a rigid boundary

Dietary changes : Patients starting GLP-1 therapy often make significant dietary modifications, including increased vegetable and fruit consumption (which have high water content) and reduced processed food intake

But cardiovascular health depends less on how much weight you lose and more on what kind of weight you lose

Most patients experience the greatest GI impact during the first few weeks after starting treatment or following dose increases